1. S117 RSIV. F/HN-mediated gene therapy enables lungs to produce therapeutically relevant levels of FVIII. (12th November 2015) Authors: Pytel, KM; Paul-Smith, MC; McIntosh, J; Chan, M; Meng, C; Pringle, I; Davis, L; Inoue, M; Hasegawa, M; Hyde, SC; Gill, DR; Nathwani, AC; Alton, EWFW; Griesenbach, U Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S120 Gene therapy for pulmonary alveolar proteinosis. (15th November 2017) Authors: Atsumi, N; Pilou, A; Pringle, I; Ashworth, RC; Meng, C; Chan, M; Gill, DR; Hyde, S; Morgan, C; Alton, EWFW; Griesenbach, U Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S127 Gene therapy for alpha-1-antitrypsin deficiency using a pseudotyped lentivirus vector. (12th November 2015) Authors: Paul-Smith, MC; Gelinas, JF; Pytel, K; Chan, M; Meng, C; Cammack, L; Cameron, L; Moran, C; Pringle, I; Davies, L; Inoue, M; Hasegawa, M; Hyde, SC; Gill, DR; Alton, EWFW; Griesenbach, U Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. T2 Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis. (December 2018) Authors: Lund-Palau, H; Meng, C; Pilou, A; Atsumi, N; Bhargava, A; Chan, M; Byrne, A; Pringle, I; Ashworth, R; Gill, D; Hyde, S; Morgan, C; Alton, E; Griesenbach, U Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗